Clinical Trials: A Phase 1b/2 Study to Evaluate the Safety and Efficacy of AMG 655 or AMG 479 in Combination With Gemcitabine as First-Line Therapy for Metastatic Pancreatic Cancer
Sponsor and CollaboratorsAmgen
Contact
Amgen Call Center
866-572-6436
Principal Investigator
MD Amgen
ClinicalTrials.gov Identifier
NCT00630552
